David Angulo

David Angulo is currently the Chief Executive Officer and Chief Medical Officer at SCYNEXIS, a biotechnology company focused on developing innovative anti-infective therapies. David previously held positions at Brickell Biotech, Inc. as Vice President, Research and Development, and at Stiefel as Vice President, Clinical Research. Before that, David worked at Schering-Plough as an Executive Director in Global Clinical Research. David holds a MD in Infectious Diseases from the Universidad Nacional Autónoma de México.